Concert Pharmaceuticals
CNCE
#7196
Rank
ยฃ0.32 B
Marketcap
ยฃ6.86
Share price
0.00%
Change (1 day)
86.73%
Change (1 year)

Revenue for Concert Pharmaceuticals (CNCE)

Revenue in 2022 (TTM): ยฃ0.03 Million

According to Concert Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is ยฃ0.03 Million. In 2021 the company made a revenue of ยฃ24.13 Million an increase over the revenue in the year 2020 that were of ยฃ5.79 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Concert Pharmaceuticals from 2013 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) ยฃ0.03 M-99.86%
2021 ยฃ24.13 M316.32%
2020 ยฃ5.79 M605.84%
2019 ยฃ0.82 M-90.08%
2018 ยฃ8.27 M-92.23%
2017 ยฃ0.10 B75400.19%
2016 ยฃ0.14 M-99.69%
2015 ยฃ45.02 M717.46%
2014 ยฃ5.5 M-64.24%
2013 ยฃ15.4 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ45.52 B 132,221,328.57%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.19 B 559,466.67%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.27 B 9,506,357.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ0.66 M 1,823.81%๐Ÿ‡บ๐Ÿ‡ธ USA